498 related articles for article (PubMed ID: 11587568)
21. Site-specific glycosylation analysis of the bovine lysosomal alpha-mannosidase.
Faid V; Evjen G; Tollersrud OK; Michalski JC; Morelle W
Glycobiology; 2006 May; 16(5):440-61. PubMed ID: 16449350
[TBL] [Abstract][Full Text] [Related]
22. Determination of N-glycosylation sites and site heterogeneity in a monoclonal antibody by electrospray quadrupole ion-mobility time-of-flight mass spectrometry.
Olivova P; Chen W; Chakraborty AB; Gebler JC
Rapid Commun Mass Spectrom; 2008; 22(1):29-40. PubMed ID: 18050193
[TBL] [Abstract][Full Text] [Related]
23. Glycoproteomics of N-glycosylation by in-gel deglycosylation and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry mapping: application to congenital disorders of glycosylation.
Sagi D; Kienz P; Denecke J; Marquardt T; Peter-Katalinić J
Proteomics; 2005 Jul; 5(10):2689-701. PubMed ID: 15912511
[TBL] [Abstract][Full Text] [Related]
24. The sperm agglutination antigen-1 (SAGA-1) glycoforms of CD52 are O-glycosylated.
Parry S; Wong NK; Easton RL; Panico M; Haslam SM; Morris HR; Anderson P; Klotz KL; Herr JC; Diekman AB; Dell A
Glycobiology; 2007 Oct; 17(10):1120-6. PubMed ID: 17640971
[TBL] [Abstract][Full Text] [Related]
25. Fc glycans terminated with N-acetylglucosamine residues increase antibody resistance to papain.
Raju TS; Scallon B
Biotechnol Prog; 2007; 23(4):964-71. PubMed ID: 17571902
[TBL] [Abstract][Full Text] [Related]
26. Site-specific N-glycan characterization of human complement factor H.
Fenaille F; Le Mignon M; Groseil C; Ramon C; Riandé S; Siret L; Bihoreau N
Glycobiology; 2007 Sep; 17(9):932-44. PubMed ID: 17591618
[TBL] [Abstract][Full Text] [Related]
27. Ammonium ion and glucosamine dependent increases of oligosaccharide complexity in recombinant glycoproteins secreted from cultivated BHK-21 cells.
Gawlitzek M; Valley U; Wagner R
Biotechnol Bioeng; 1998 Mar; 57(5):518-28. PubMed ID: 10099230
[TBL] [Abstract][Full Text] [Related]
28. Comparative study of the N-glycans of human monoclonal immunoglobulins M produced by hybridoma and parental cells.
Fukuta K; Abe R; Yokomatsu T; Kono N; Nagatomi Y; Asanagi M; Shimazaki Y; Makino T
Arch Biochem Biophys; 2000 Jun; 378(1):142-50. PubMed ID: 10871054
[TBL] [Abstract][Full Text] [Related]
29. Site-specific N-glycosylation of chicken serum IgG.
Suzuki N; Lee YC
Glycobiology; 2004 Mar; 14(3):275-92. PubMed ID: 14693911
[TBL] [Abstract][Full Text] [Related]
30. A rapid sample preparation method for mass spectrometric characterization of N-linked glycans.
Yu YQ; Gilar M; Kaska J; Gebler JC
Rapid Commun Mass Spectrom; 2005; 19(16):2331-6. PubMed ID: 16041822
[TBL] [Abstract][Full Text] [Related]
31. Analysis of lysine clipping of a humanized Lewis-Y specific IgG antibody and its relation to Fc-mediated effector function.
Antes B; Amon S; Rizzi A; Wiederkum S; Kainer M; Szolar O; Fido M; Kircheis R; Nechansky A
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):250-6. PubMed ID: 17296336
[TBL] [Abstract][Full Text] [Related]
32. N-glycan structures and N-glycosylation sites of mouse soluble intercellular adhesion molecule-1 revealed by MALDI-TOF and FTICR mass spectrometry.
Otto VI; Damoc E; Cueni LN; Schürpf T; Frei R; Ali S; Callewaert N; Moise A; Leary JA; Folkers G; Przybylski M
Glycobiology; 2006 Nov; 16(11):1033-44. PubMed ID: 16877748
[TBL] [Abstract][Full Text] [Related]
33. Mass spectrometry and HPLC for carbohydrate analysis.
Siemiiatkoski J; Lyubarskaya Y
Dev Biol (Basel); 2005; 122():69-74. PubMed ID: 16375251
[TBL] [Abstract][Full Text] [Related]
34. Influence of culture conditions on the N-glycosylation of a monoclonal antibody specific for recombinant hepatitis B surface antigen.
Cabrera G; Cremata JA; Valdés R; García R; González Y; Montesino R; Gómez H; González M
Biotechnol Appl Biochem; 2005 Feb; 41(Pt 1):67-76. PubMed ID: 15049731
[TBL] [Abstract][Full Text] [Related]
35. Anti-melanoma effects of R24, a monoclonal antibody against GD3 ganglioside.
Nasi ML; Meyers M; Livingston PO; Houghton AN; Chapman PB
Melanoma Res; 1997 Aug; 7 Suppl 2():S155-62. PubMed ID: 9578432
[TBL] [Abstract][Full Text] [Related]
36. Improved effector functions of a therapeutic monoclonal Lewis Y-specific antibody by glycoform engineering.
Schuster M; Umana P; Ferrara C; Brünker P; Gerdes C; Waxenecker G; Wiederkum S; Schwager C; Loibner H; Himmler G; Mudde GC
Cancer Res; 2005 Sep; 65(17):7934-41. PubMed ID: 16140965
[TBL] [Abstract][Full Text] [Related]
37. N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits.
Koles K; van Berkel PH; Pieper FR; Nuijens JH; Mannesse ML; Vliegenthart JF; Kamerling JP
Glycobiology; 2004 Jan; 14(1):51-64. PubMed ID: 14514717
[TBL] [Abstract][Full Text] [Related]
38. N-linked glycan structures of a mouse monoclonal antibody produced from tobacco BY2 suspension-cultured cells.
Fujiyama K; Misaki R; Katsura A; Tanaka T; Furukawa A; Omasa T; Seki T
J Biosci Bioeng; 2006 Mar; 101(3):212-8. PubMed ID: 16716920
[TBL] [Abstract][Full Text] [Related]
39. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
[TBL] [Abstract][Full Text] [Related]
40. Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells.
Beck A; Bussat MC; Zorn N; Robillard V; Klinguer-Hamour C; Chenu S; Goetsch L; Corvaïa N; Van Dorsselaer A; Haeuw JF
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):203-18. PubMed ID: 15833284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
